A novel drug repurposing approach for non-small cell lung cancer using deep learning.
Drug repurposing is an attractive and pragmatic way offering reduced risks and development time in the complicated process of drug discovery. In the past, drug repurposing has been largely accidental and serendipitous. The most successful examples so far have not involved a systematic approach. Nowa...
Main Authors: | Bingrui Li, Chan Dai, Lijun Wang, Hailong Deng, Yingying Li, Zheng Guan, Haihong Ni |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0233112 |
Similar Items
-
Elucidating drug repurposing in non-small cell lung cancer via microarray-based profiling
by: Cheng-Hao Yu, et al.
Published: (2015) -
Antifungal Drug Repurposing
by: Jong H. Kim, et al.
Published: (2020-11-01) -
SPIDR: small-molecule peptide-influenced drug repurposing
by: Matthew D. King, et al.
Published: (2018-04-01) -
Repurposing drugs for the treatment of glioma
by: Chengming Xu, et al.
Published: (2019-01-01) -
Repurposing Antidiabetic Drugs for Cardiovascular Disease
by: Mario Schubert, et al.
Published: (2020-09-01)